CNS Oncology
CNS Oncology addresses key issues and current understanding in the diagnosis, staging and treatment of neurological malignancies by exploring the best patient-centered clinical research and presenting this information both directly, as clinical findings, and in practice-oriented formats of direct relevance in the clinic.
CNS Oncology provides oncologists and other health professionals with the latest findings and opinions on reducing the burden of this widespread disease. Recent research findings and advances in clinical practice in the field are reported and analyzed by international experts, and the importance of the most recent advances in molecular biology are explained.
High-quality, methodologically sound papers are considered in the following areas diagnosis and imaging, staging, epidemiology, patient perspectives, pharmacoeconomics and outcomes research, pathology, palliative care, radiotherapy, chemotherapy, surgical approaches, systemic therapies, adjuvant therapy, biomarkers, comparative effectiveness, molecular biology of CNS disease, molecular diagnostics and prevention.
The journal welcomes unsolicited article proposals, including for the submission of original research, narrative and systematic reviews, and opinion pieces.